This CME offering will review some clinical practice guidelines for the primary care provider assessing patients for fracture risk and review the role of calcium and vitamin D requirements in the setting of osteoporosis. Some practical tips are provided regarding use of FRAX and organization of clinical notes. The mechanism of action and the use of FDA approved medications for treatment of osteoporosis will be discussed.
Dates and Times
End Date: 5/4/2026
As a result of this educational activity, webcast participants will be able to:
- Discuss Basics and Scope of Osteoporosis Problem
- Review Fracture Risk Evaluation including clinical tips
- Describe the treatment of osteoporosis, including non-pharmacological recommendations.
- Review the mechanism of action of the medications currently FDA approved for osteoporosis treatment and the data supporting their anti-fracture efficacy.
- Create an algorithm for the choice of treatment once fracture risk is found to be high.
The Center for Continuing Medical Education (CCME) at The Ohio State University is accredited by the Accreditation Council for Continuing Medical Education (ACCME®) to provide continuing medical education for physicians
The Center for Continuing Medical Education (CCME) at The Ohio State University designates this webcasts for a maximum of 1.00 AMA PRA Category 1 Credit(s) ™. Physicians should only claim credit commensurate with the extent of their participation in the activity.